【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market overview
03.2 Product offerings
04.Product Profiles
04.1.1 Celexa
04.1.2 Fetzima
04.1.3 Lexapro
04.1.4 Viibryd
04.1.5 Cymbalta
04.1.6 Prozac
04.1.7 Symbyax
04.1.8 Paxil
04.1.9 Wellbutrin
04.1.10 Abilify
04.1.11 Effexor
04.1.12 Pristiq
04.1.13 Zoloft
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disorder Overview
07.1 Types of depression
07.1.1 Major depressive disorder
07.1.2 Persistent depressive disorder
07.1.3 Psychotic depression
07.1.4 Postpartum depression
07.1.5 Seasonal affective disorder
07.1.6 Bipolar disorder
07.2 Etiology
07.3 Epidemiology
07.3.1 Bipolar disorder among adults
07.3.2 Dysthymic disorder among adults
07.3.3 Major depression among adults
07.3.4 Major depression among adolescents
07.4 Treatment and management
07.5 Economic burden
08.Market Landscape
08.1 Market overview
08.2 Market size and forecast
08.3 Depression drugs market in US 2014-2019
08.3.1 Market size and forecast
08.4 Five forces analysis
09.Market Segmentation by Mechanism of Action
10.Geographical Segmentation
10.1 Segmentation of global depression drugs market by geography 2014
11.Pipeline Portfolio
11.1 Key information on late-stage pipeline molecules
11.1.1 Brexpiprazole
11.1.2 ALKS 5461
11.1.3 Cariprazine
11.1.4 TGFK07AD
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.2.1 Competitive assessment of top drugs used for treating depression
19.2.2 Bristol-Myers Squibb
19.2.3 Eli Lilly
19.2.4 Pfizer
19.2.5 GlaxoSmithKline
19.2.6 Actavis
19.3 Other and future prominent vendors
20.Key Vendor Analysis
20.1 Actavis
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical segmentation by Sales 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 Bristol-Myers Squibb
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Key Product Offerings
20.2.4 Revenue by Geography
20.2.5 Business Strategy
20.2.6 Key Information
20.2.7 SWOT Analysis
20.3 Eli Lilly
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue
20.3.4 Sales by Geography
20.3.5 Business Strategy
20.3.6 Key Information
20.3.7 SWOT Analysis
20.4 GlaxoSmithKline
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2014
20.4.4 Business segmentation by revenue 2013 and 2014
20.4.5 Geographical segmentation by revenue 2014
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
20.5 Pfizer
20.5.1 Key facts
20.5.2 Business overview
20.5.3 Business segmentation by revenue 2014
20.5.4 Business segmentation by revenue 2013 and 2014
20.5.5 Geographical segmentation by revenue 2014
20.5.6 Business strategy
20.5.7 Key developments
20.5.8 SWOT analysis
21.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: NIMH classification of depression
Exhibit 3: Prevalence data for major depressive disorder among adults in US (2012)
Exhibit 4: Prevalence data for dysthymic disorder among adults in US (2012)
Exhibit 5: 12-month prevalence data for major depressive disorder with severe impairment among adults in US (2012)
Exhibit 6: Prevalence data for major depressive disorder among adults in US (2012)
Exhibit 7: Prevalence data for major depression among adults in US (2012)
Exhibit 8: WHO guidelines for management of depression
Exhibit 9: Economic burden of depression in US
Exhibit 10: Segmentation of costs associated with depression
Exhibit 11: Snapshot of economic burden of depression in US
Exhibit 12: Global depression drugs market 2014-2019 ($ millions)
Exhibit 13: Depression drugs market in US 2014-2019 ($ millions)
Exhibit 14: Segmentation of global depression drugs market by mechanism of action
Exhibit 15: Segmentation of global depression drugs market by mechanism of action 2014
Exhibit 16: Segmentation of global depression drugs market by geography 2014
Exhibit 17: Depression drugs: pipeline portfolio
Exhibit 18: Vendor ranking 2014
Exhibit 19: YoY growth rate of major depression drugs 2010-2014 ($ millions)
Exhibit 20: Revenue comparison of top drugs used for treating depression in 2013 ($ millions)
Exhibit 21: YoY global revenue of Abilify 2010-2014 ($ millions)
Exhibit 22: YoY global revenue of Cymbalta 2010-2014 ($ millions)
Exhibit 23: YoY global revenue of Pristiq 2010-2014 ($ millions)
Exhibit 24: YoY global revenue of Zoloft 2010-2014 ($ millions)
Exhibit 25: YoY global revenue of Effexor 2010-2014 ($ millions)
Exhibit 26: YoY global revenue of Wellbutrin 2010-2013 ($ millions)
Exhibit 27: YoY revenue of Wellbutrin in US 2010-2013 ($ millions)
Exhibit 28: YoY global revenue of Paxil 2010-2014 ($ millions)
Exhibit 29: Actavis: Business Segmentation
Exhibit 30: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 31: Actavis: Geographical segmentation by Sales 2013
Exhibit 32: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 33: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 34: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 35: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 36: Eli Lilly: Sales by Geography 2013
Exhibit 37: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 38: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 39: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 40: Pfizer: Business segmentation by revenue 2014
Exhibit 41: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 42: Pfizer: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル：うつ病治療薬の世界市場2015-2019■ 英文：Global Depression Drugs Market 2015-2019
■ 発行日：2015年6月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6053
■ 調査対象地域：グローバル
- 世界のVoice over Mobile Broadband (VoMBB)市場動向（2012-2016）Global Voice over Mobile Broadband (VoMBB) Market 2012-2016 Voice over Mobile Broadband, or VoMBB, has been recently gaining traction in the Global Telecom industry and is unanimously expected to generate huge revenue for telecom network operators in the coming years. Conceptually, VoMBB is about encompassing carrier-grade voice calls over LTE, Wi-Fi and HSPA/HSPA+ networks. While Wi-Fi is a nifty …
- 軍事用電気光学・赤外線（EO/IR）システムの世界市場Summary The Global Military Electro Optical Infrared (EO/IR) Systems Market 2015-2025report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global military EO …
- パーソナルケア製品用包装の世界市場2018-2022About Global Personal Care Packaging Market Personal care packaging vendors provide various packaging solutions, ranging from standard to customized solutions for different personal care sectors such as skin care, hair care, cosmetics, and toiletries. Technavio’s analysts forecast the Global Personal Care Packaging Market to grow at a CAGR of 5.99% during the period 2018-2022. Covered in this repo …
- 政府向け生体認証システムの世界市場：地域別分析Summary This report offers detailed analysis of the global Government Biometric Systems market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Government Biometric Systems market. Key Findings "The Global Government Biometric Systems Market 2015-2025 - Country Analysis: Market Profile" provide …
- ヒトパピローマウイルス（HPV）治療薬の世界市場2019-2023About this market Technological advances in diagnostics to drive market growth. The diagnostic methods that are currently available in the market include Pap test, colposcopy, and HPV DNA test. Pap test is a screening procedure for cervical cancer, in which the presence of precancerous or cancerous cells is identified on the cervix. Colposcopy is a more advanced technique like a Pap test, which al …
- 世界のM2Mネットワークセキュリティ製品市場（2014-2018）About M2M Network Security M2M communications enable data sharing between two or more machines in real time. A sensor attached to the machine captures the event and relays through a secure network, which can be wireless or wired. It then collects at the other side to initiate the necessary action. M2M communications have numerous advantages for organizations as it reduces human intervention and en …
- プロテインC及びプロテインS検査市場：米国、ヨーロッパ、日本The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Proteins C and S testing specifically, will become more standardized, off …
- 世界のM2M無線サービス市場動向（2012-2016）TechNavio's analysts forecast the Global M2M Wireless Network Services market to grow at a CAGR of 29.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the new income opportunities for Mobile Network Operators. The Global M2M Wireless Network Services market has also been witnessing the trend of global telecom heading towards the data era. However, …
- VPU（ビジュアルプロセッシングユニット）の世界市場予測（～2024年）“VPU market to grow at 18.69% CAGR from 2018 to 2024” The VPU market is expected to grow from USD 1.3 billion in 2019 to USD 3.2 billion by 2024 at a CAGR of 18.7%. The need for VPUs is mainly governed by the increasing adoption of premium smartphones, growing adoption of edge AI, rising demand for high-end computing capabilities for computer and machine vision. However, the availability of CPUs a …
- 世界のメールセキュリティ市場動向（2014～2018）TechNavio's analysts forecast the Global Messaging Security market to grow at a CAGR of 12.7 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing popularity of cloud-based secure messaging. The Global Messaging Security market has also been witnessing increasing R&D spending by vendors. However, the increasing complexity of network infrastr …
- 3Dセンシング技術の世界市場展望2017-20276According to Stratistics MRC, the Global 3D Sensing Technology Market is accounted for $882.10 million in 2017 and is expected to reach $4,982.90 million by 2026 growing at a CAGR of 21.2% during the forecast period. Some of the key factors influencing the market growth include increase in demand of biometric authentication, growing demand for 3d sensors in consumer electronics and increase in num …
- 政府向け生体認証システムの世界市場：競争環境及び戦略的インサイトSummary This report shows the leading Government Biometric Systems market segments in various regions across the world. Details of top companies active across the global Government Biometric Systems market are provided, together with market size and forecast 2013-2023 for the main players across those areas. Key Findings The report provides a detailed analysis of the competitive landscape of the G …
- ハードウェアOTPトークン認証の世界市場2016-2020About Hardware OTP Authentication Hardware OTP authentication method enables organizations to secure their data with two-factor authentication. The hardware device that is being used is the first step of authentication followed by a security token that is issued to the user to verify the identity of the user. This two-factor authentication method enables secure business transactions and enhances u …
- AWE Limited：石油・ガスの開発・生産動向及びコスト分析– 2012AWE Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary AWE Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational dat …
- マイコプラズマ試験の世界市場分析：製品別、技術別（PCR、ELISA、直接アッセイ、微生物培養技術）、用途別（細胞株、ウイルス、生産終了細胞試験）、エンドユーザー別、セグメント予測、2014-2025The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of …
